Authors: SAAF M HILDING A WIVALLHELLERYD IL BAYLINK DJ MOHAN S THOREN M

Citation: M. Saaf et al., INSULIN-LIKE GROWTH-FACTORS (IGFS) AND THEIR BINDING-PROTEINS (BP)-4 AND (BP)-5 BEFORE AND DURING GH THERAPY TO WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS, Journal of bone and mineral research, 12, 1997, pp. 552-552

Authors: THOREN M HILDING A BAXTER RC DEGERBLAD M WIVALLHELLERYD IL HALL K

Citation: M. Thoren et al., SERUM INSULIN-LIKE GROWTH-FACTOR-I (IGF-I), IGF-BINDING PROTEIN-1 ANDPROTEIN-3, AND THE ACID-LABILE SUBUNIT AS SERUM MARKERS OF BODY-COMPOSITION DURING GROWTH-HORMONE (GH) THERAPY IN ADULTS WITH GH DEFICIENCY, The Journal of clinical endocrinology and metabolism, 82(1), 1997, pp. 223-228

Authors: THOREN MC WIVALLHELLERYD IL BLUM WF HALL KE

Citation: Mc. Thoren et al., EFFECTS OF REPEATED SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR-I IN ADULTS WITH GROWTH-HORMONE DEFICIENCY, European journal of endocrinology, 131(1), 1994, pp. 33-40

Authors: THOREN M WIVALLHELLERYD IL HALL K

Citation: M. Thoren et al., EFFECTS OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR-I ADMINISTRATION IN ADULTS WITH GROWTH-HORMONE DEFICIENCY, Acta paediatrica, 82, 1993, pp. 45-48